4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-053349
Chief Executive Officer sold 8,581 shares at $1.58 ($13,558)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-19 | Sale : show line 1 in the form 10b5-1 | −8,581 | $1.58 | $13,558 | 881,977 | D |
| Open-market sales · 8,581 sh · avg $1.58 · $13,558 | ||||||
Loading xslF345X05/doc4.xml…